CIDRAP newsletters options
The US case total now stands at 3,134 as the Pennsylvania outbreak expands.
Research finds people are more likely to believe someone’s request for a religious exemption is sincere when the desired outcome aligns with their own political ideology.
Although 10% of Americans believe they have a penicillin allergy, less than 1% are truly allergic to the antibiotic. Being inaccurately labeled can be risky for your health.
Participants who met physical activity recommendations before infection had a 20% lower rate of functional disability 2 years later than those who didn’t.
Michigan has now reported 14,718 cases in a cyclosporiasis outbreak linked to iceberg lettuce.
Things no longer reliably provided by the CDC: What vaccines are recommended, whether you can walk in and get one, and what's happening with disease in the US.
Female pediatricians reported higher rates of burnout than their male peers in 2025.
The disease is characterized by fever, fatigue, gastrointestinal symptoms, and abnormal lab findings.
A new study sheds light on the immune cells responsible for producing autoantibodies in people with COVID.
A family in Lancaster County lost a newborn and then heard the HHS secretary suggest their child's death might have been invented. They deserve better.
Officials are using anonymized phone data used to track population movements in the outbreak region.
It is unclear if this is a new death, or the second death reported last week.
A CDC-led investigation identified 12 deaths linked to ceftriaxone injections at healthcare facilities in 18 states over 11 months.
A new CDC report shows most cases are from new transmission chains.
The vaccine was an estimated 73% effective at preventing hospitalizations and 56% effective in protecting against death.
On June 25 of this year, Michigan officials notified the CDC of an increase in Cyclospora cases in the state.
The groups, along with other leading US medical organizations, offer vaccine recommendations for the upcoming respiratory illness season.
Our researchers systematically reviewed the newest scientific evidence on flu, COVID-19, and RSV immunizations, examining effectiveness and safety.
The increased risk waned considerably after the first year of follow-up, prompting the authors to say that women shouldn’t be “unduly concerned.”
Treatment with Dengue-mAb demonstrated a rapid clearance of dengue viremia and fever within 24 hours at all dose levels compared with placebo.
